Dr. John P. Morcos
Overview
John P. Morcos, MD, is a medical oncologist at Arnold Palmer Medical Oncology at Mt. Pleasant. Board-certified in hematology, oncology, and internal medicine, Dr. Morcos received his medical degree from Duke University School of Medicine. He completed his residency at Johns Hopkins Hospital in Baltimore and his fellowship at UPMC Hillman Cancer Center.
Dr. Morcos is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Familial Colorectal Cancer, and Small Cell Lung Cancer (SCLC).
Dr. Morcos is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. He is actively involved in clinical research, participating in 2 clinical trials. Dr. Morcos is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
508 South Church Street, Suite 202, Mt Pleasant, PA 15666
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy. Dr. Brufsky is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brufsky is currently accepting new patients.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.
Frequently Asked Questions about Dr. John P. Morcos
Is Dr. John P. Morcos a top-rated expert for Thrombocytopenia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John P. Morcos is classified as an Distinguished expert for Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John P. Morcos specialize in?
While Dr. John P. Morcos is a Hematology Oncology, they have specific expertise in Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. John P. Morcos accept my insurance?
Dr. John P. Morcos accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hemangioma Thrombocytopenia SyndromeDr. Morcos isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- ThrombocytopeniaDr. Morcos isDistinguished. Learn about Thrombocytopenia.
- Advanced
- Childhood Iron Deficiency AnemiaDr. Morcos isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Colorectal CancerDr. Morcos isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Morcos isAdvanced. Learn about Familial Colorectal Cancer.
- Inflammatory Breast CancerDr. Morcos isAdvanced. Learn about Inflammatory Breast Cancer.
- Iron Deficiency AnemiaDr. Morcos isAdvanced. Learn about Iron Deficiency Anemia.
- Lung CancerDr. Morcos isAdvanced. Learn about Lung Cancer.
- Experienced
- Acute Eosinophilic PneumoniaDr. Morcos isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Hepatic Porphyria (AHP)Dr. Morcos isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Morcos isExperienced. Learn about Acute Mountain Sickness.
- Adrenal CancerDr. Morcos isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Morcos isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Morcos isExperienced. Learn about Adult Soft Tissue Sarcoma.